Literature DB >> 23524652

Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Hedi Harizi1.   

Abstract

The reciprocal activating crosstalk between dendritic cells (DCs) and natural killer (NK) cells plays a pivotal role in regulating immune defense against viruses and tumors. The cytokine-producing capacity, Th-cell polarizing ability and chemokine expression, migration and stimulatory functions of DCs are regulated by activated NK cells. Conversely, the innate and effector functions of NK cells require close interactions with activated DCs. Cell membrane-associated molecules and soluble mediators, including cytokines and prostaglandins (PGs), contribute to the bidirectional crosstalk between DCs and NK cells. One of the most well-known and well-studied PGs is PGE2. Produced by many cell types, PGE2 has been shown to affect various aspects of the immune and inflammatory responses by acting on all components of the immune system. There is emerging evidence that PGE2 plays crucial roles in DC and NK cell biology. Several studies have shown that DCs are not only a source of PGE2, but also a target of its immunomodulatory action in normal immune response and during immune disorders. Although NK cells appear to be unable to produce PGE2, they are described as powerful PGE2-responding cells, as they express all PGE2 E-prostanoid (EP) receptors. Several NK cell functions (lysis, migration, proliferation, cytokine production) are influenced by PGE2. This review highlights the effects of PGE2 on DC-NK cell crosstalk and its subsequent impact on immune regulations in normal and immunopathological processes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23524652      PMCID: PMC4012770          DOI: 10.1038/cmi.2013.1

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  124 in total

Review 1.  Distribution and function of prostanoid receptors: studies from knockout mice.

Authors:  Y Sugimoto; S Narumiya; A Ichikawa
Journal:  Prog Lipid Res       Date:  2000-07       Impact factor: 16.195

2.  Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.

Authors:  Dawn M Holt; Xinrong Ma; Namita Kundu; Peter D Collin; Amy M Fulton
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

Review 3.  Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy.

Authors:  Muzammal Hussain; Aqeel Javeed; Muhammad Ashraf; Nuha Al-Zaubai; Alastair Stewart; Muhammad Mahmood Mukhtar
Journal:  Pharmacol Res       Date:  2012-02-21       Impact factor: 7.658

4.  Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.

Authors:  Xinrong Ma; Namita Kundu; Peter D Collin; Olga Goloubeva; Amy M Fulton
Journal:  Breast Cancer Res Treat       Date:  2011-07-15       Impact factor: 4.872

5.  In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines.

Authors:  L Minghetti; D T Walsh; G Levi; V H Perry
Journal:  J Neuropathol Exp Neurol       Date:  1999-11       Impact factor: 3.685

6.  Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice.

Authors:  E Kuroda; T Sugiura; K Zeki; Y Yoshida; U Yamashita
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 7.  The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions?

Authors:  B Jacobs; E Ullrich
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

8.  Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Authors:  Gabriella Pietra; Claudia Manzini; Silvia Rivara; Massimo Vitale; Claudia Cantoni; Andrea Petretto; Mirna Balsamo; Romana Conte; Roberto Benelli; Simona Minghelli; Nicola Solari; Marina Gualco; Paola Queirolo; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Cancer Res       Date:  2012-01-18       Impact factor: 12.701

9.  Differential recruitment and activation of natural killer cell sub-populations by Mycobacterium bovis-infected dendritic cells.

Authors:  Nazneen Siddiqui; Jayne Hope
Journal:  Eur J Immunol       Date:  2012-12-03       Impact factor: 5.532

10.  Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response.

Authors:  Barbara Morandi; Lorenzo Mortara; Laura Chiossone; Roberto S Accolla; Maria Cristina Mingari; Lorenzo Moretta; Alessandro Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

View more
  27 in total

1.  Frontiers in natural killer cell immunology.

Authors:  Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-05-04       Impact factor: 11.530

2.  Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma.

Authors:  Matthew C Altman; Elizabeth Whalen; Alkis Togias; George T O'Connor; Leonard B Bacharier; Gordon R Bloomberg; Meyer Kattan; Robert A Wood; Scott Presnell; Petra LeBeau; Katy Jaffee; Cynthia M Visness; William W Busse; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2018-03-05       Impact factor: 10.793

3.  IL-1β limits the extent of human 6-sulfo LacNAc dendritic cell (slanDC)-mediated NK cell activation and regulates CD95-induced apoptosis.

Authors:  Dejene Milkessa Tufa; Fareed Ahmad; Debanjana Chatterjee; Gerrit Ahrenstorf; Reinhold Ernst Schmidt; Roland Jacobs
Journal:  Cell Mol Immunol       Date:  2016-04-18       Impact factor: 11.530

4.  Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice.

Authors:  Andrea Sobo-Vujanovic; Lazar Vujanovic; Albert B DeLeo; Fernando Concha-Benavente; Robert L Ferris; Yan Lin; Nikola L Vujanovic
Journal:  Cancer Immunol Res       Date:  2016-02-19       Impact factor: 11.151

5.  Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases.

Authors:  Zongmin Zhao; Anvay Ukidve; Vinu Krishnan; Alexandra Fehnel; Daniel C Pan; Yongsheng Gao; Jayoung Kim; Michael A Evans; Abhirup Mandal; Junling Guo; Vladimir R Muzykantov; Samir Mitragotri
Journal:  Nat Biomed Eng       Date:  2020-11-16       Impact factor: 25.671

6.  TREM2 promotes natural killer cell development in CD3-CD122+NK1.1+ pNK cells.

Authors:  Hwa-Youn Lee; Eun-Hee Lee; Jawoon Yi; Kon-Young Ji; Su-Man Kim; Ha-Rim Choi; Su-Min Yee; Hyung-Sik Kang; Eun-Mi Kim
Journal:  BMC Immunol       Date:  2021-05-12       Impact factor: 3.615

Review 7.  Blocking prostanoid receptors switches on multiple immune responses and cascades of inflammatory signaling against larval stages in snail fever.

Authors:  Sameh Saber; Suliman Y Alomar; Galal Yahya
Journal:  Environ Sci Pollut Res Int       Date:  2022-04-09       Impact factor: 5.190

Review 8.  The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity.

Authors:  Hedi Harizi
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

Review 9.  NKp30 - A prospective target for new cancer immunotherapy strategies.

Authors:  Pedro F Pinheiro; Gonçalo C Justino; M Matilde Marques
Journal:  Br J Pharmacol       Date:  2020-08-26       Impact factor: 8.739

10.  Serum HBV pregenomic RNA exhibited opposite associations with NKdim and NKbright cell immunity in treatment-naïve chronic hepatitis B patients.

Authors:  Yurong Gu; Zexuan Huang; Xiaoyan Li; Youming Chen; Chunhong Liao; Yanhua Bi; Yuehua Huang
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.